Physician profile
Scott Holekamp
NPI 1831357003
$3,776.43
in general payments reported to CMS, 2019-2025
19 companies · $238 in 2025
The $238 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2020: $308 · 2021: $277 · 2022: $198 · 2023: $2,325 · 2024: $244 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,000 · Food and Beverage: $884 · Travel and Lodging: $822 · Gift: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,000.00 |
| Food and Beverage | $884.02 |
| Travel and Lodging | $821.65 |
| Gift | $101.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,104.68 | 2022-2023 | Da Vinci Surgical System, Davinci Xi |
| Braintree Laboratories, INC. | $471.68 | 2019-2025 | Sutab, Suflave |
| Ethicon US, LLC | $259.30 | 2020-2025 | Enseal, Echelon Circular, Echelon; Endopath |
| Covidien LP | $156.72 | 2019 | |
| Axonics, INC. | $124.28 | 2020-2021 | |
| Thd America, INC. | $80.14 | 2020-2025 | |
| Pacira Pharmaceuticals Incorporated | $78.48 | 2020-2025 | Exparel |
| Cumberland Pharmaceuticals, INC. | $75.47 | 2023-2025 | Caldolor |
| Davol INC. | $70.35 | 2020-2022 | |
| Smith+Nephew, INC. | $60.39 | 2021-2025 | Grafix Pl, Renasys Go V2 Home |
| Stryker Corporation | $55.97 | 2020-2024 | Stryker |
| Organogenesis INC. | $47.73 | 2025 | Puraply Wound Matrix |
| Integra Lifesciences Corporation | $47.44 | 2023 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Coloplast Corp | $45.31 | 2023 | Sensura Mio |
| Kerecis Limited | $29.33 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $22.48 | 2025 | Restrata Wound Matrix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.60 | 2019 | |
| Ferring Pharmaceuticals INC. | $15.22 | 2021 | |
| Solventum Corporation | $14.86 | 2025 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Holekamp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.